Prevalence of atherosclerotic renal artery stenosis in patients starting dialysis

被引:81
作者
van Ampting, JMA
Penne, EL
Beek, FJA
Koomans, HA
Boer, WH
Beutler, JJ
机构
[1] Univ Utrecht, Ctr Med, Dept Hypertens & Nephrol, NL-3508 GA Utrecht, Netherlands
[2] Univ Utrecht, Ctr Med, Dept Radiol, NL-3508 GA Utrecht, Netherlands
关键词
atherosclerosis; renal artery stenosis; renal failure; renal replacement therapy;
D O I
10.1093/ndt/gfg121
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Atherosclerotic renal artery stenosis (ARAS) can lead to end-stage renal failure (ESRF). We determined the prevalence of ARAS in patients 45 years of age or older starting renal replacement therapy. Methods. Forty-nine of 80 consecutive patients (37 males, 12 females) starting renal replacement therapy in our centre gave informed consent and underwent spiral computed tomographic angiography of their renal arteries. A renal artery diameter reduction of 50% or more assessed by two radiologists was considered as a significant stenosis. Results. Twenty of 49 patients (41%) had an ARAS, and in eight cases (16%) this was bilateral or unilateral with a single kidney. Women were more likely to have an ARAS than men; 75 (9/12) vs 30% (11/37, P < 0.01). However, relatively more women declined participation. Non-participants and participants did not differ in respect to other relevant clinical data. Nonetheless, findings in these patients would be negative, the prevalence of ARAS would still be 31% in women and 22% in men (NS). In 13 patients with ARAS the registered diagnosis of ESRF either was hypertension, renovascular disease or unknown. Assuming that in these patients atherosclerotic renovascular disease was the cause of renal failure, a total of 13 patients (13/49, 27%) entered the dialysis programme because of this problem. Conclusions. These results suggest that ARAS is an important cause of ESRF.
引用
收藏
页码:1147 / 1151
页数:5
相关论文
共 20 条
[1]   RENOVASCULAR DISEASE IN OLDER PATIENTS BEGINNING RENAL REPLACEMENT THERAPY [J].
APPEL, RG ;
BLEYER, AJ ;
REAVIS, S ;
HANSEN, KJ .
KIDNEY INTERNATIONAL, 1995, 48 (01) :171-176
[2]   Incidence of end-stage renal disease in medically treated patients with severe bilateral atherosclerotic renovascular disease [J].
Baboolal, K ;
Evans, C ;
Moore, RH .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (06) :971-977
[3]  
Beutler JJ, 2001, J AM SOC NEPHROL, V12, P1475, DOI 10.1681/ASN.V1271475
[4]   Risk of atrophy in kidneys with atherosclerotic renal artery stenosis [J].
Caps, MT ;
Zierler, RE ;
Polissar, NL ;
Bergelin, RO ;
Beach, KW ;
Cantwell-Gab, K ;
Casadei, A ;
Davidson, RC ;
Strandness, ED .
KIDNEY INTERNATIONAL, 1998, 53 (03) :735-742
[5]   Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States [J].
Fatica, RA ;
Port, FK ;
Young, EW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (06) :1184-1190
[6]   SURGICAL-MANAGEMENT OF DIALYSIS-DEPENDENT ISCHEMIC NEPHROPATHY [J].
HANSEN, KJ ;
THOMPSON, RB ;
CRAVEN, TE ;
FULLER, SB ;
KEITH, DR ;
APPEL, RG ;
DEAN, RH .
JOURNAL OF VASCULAR SURGERY, 1995, 21 (02) :197-211
[7]   Effect of renal-artery stenting on progression of renovascular renal failure [J].
Harden, PN ;
MacLeod, MJ ;
Rodger, RSC ;
Baxter, GM ;
Connell, JMC ;
Dominiczak, AF ;
Junor, BJR ;
Briggs, JD ;
Moss, JG .
LANCET, 1997, 349 (9059) :1133-1136
[8]   Renal artery stenosis: Detection and quantification with spiral CT angiography versus optimized digital subtraction angiography [J].
Kaatee, R ;
Beek, FJA ;
deLange, EE ;
vanLeeuwen, MS ;
Smits, HFM ;
vanderVen, PJG ;
Beutler, JJ ;
Mali, WPTM .
RADIOLOGY, 1997, 205 (01) :121-127
[9]  
KAHN IH, 1993, LANCET, V341, P415
[10]   REVERSAL OF END STAGE RENAL-FAILURE WITH SURGICAL REVASCULARIZATION IN PATIENTS WITH ATHEROSCLEROTIC RENAL-ARTERY OCCLUSION [J].
KAYLOR, WM ;
NOVICK, AC ;
ZIEGELBAUM, M ;
VIDT, DG .
JOURNAL OF UROLOGY, 1989, 141 (03) :486-488